"Loading Stock Price & Valuation Data ..."
Unlock News Summary by Subscribing to iPick.ai Premium!
Ask anything related to BNTC. [ FAQ on what and how to ask] For non-BNTC questions, click the logo in the upper-right corner to return to the main page and ask there.
CEO:Dr. Jerel A. Banks M.D., Ph.D.
Headquarter: 3940 Trust Way, Hayward, CA, United States, 94545
Industry: Biotechnology, Investment Track: gene therapy - small, Employees: 19
Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. Its Silence and Replace, a DNA-directedRNA interference platform combines RNA interference with gene therapy to create medicines that simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct. The company is developing BB-301, an AAV-based gene therapy designed to silence the expression of the disease-causing gene for the treatment of oculopharyngeal muscular dystrophy related dysphagia. Benitec Biopharma Inc. is headquartered in Hayward, California.
My Watchlist
